Abington Cole + Ellery is currently conducting a class action investigation regarding a confirmed data security incident affecting personal and medical information entrusted to Quest Diagnostics.
Quest Diagnostics reported via press release that on May 14, 2019, it was informed by American Medical Collection Agency (AMCA), a billing collections service provider, that an unauthorized user had access to AMCA’s system containing personal information AMCA received from various entities, including from Quest Diagnostics.
AMCA first notified Quest Diagnostics on May 14, 2019, of potential unauthorized activity on AMCA’s web payment page. On May 31, 2019, AMCA notified Quest Diagnostics that the data on AMCA’s affected system included information regarding approximately 11.9 million Quest Diagnostics patients. It is believed information that was part of the incident includes: personal information, including certain financial data, Social Security numbers, and medical information, but not laboratory test results.
If you believe you are a victim of the Quest Diagnostics data security incident, and would like to participate in a class action lawsuit regarding this data security incident, please submit your information via the form on this webpage.
This website is not associated with nor authorized by Quest Diagnostics or any affiliated companies.